Literature DB >> 27930335

Chromosome instability drives phenotypic switching to metastasis.

ChongFeng Gao1, Yanli Su2, Julie Koeman3, Elizabeth Haak2, Karl Dykema3, Curt Essenberg2, Eric Hudson3, David Petillo4, Sok Kean Khoo5, George F Vande Woude1.   

Abstract

Chromosome instability (CIN) is the most striking feature of human cancers. However, how CIN drives tumor progression to metastasis remains elusive. Here we studied the role of chromosome content changes in generating the phenotypic dynamics that are required for metastasis. We isolated epithelial and mesenchymal clones from human carcinoma cell lines and showed that the epithelial clones were able to generate mesenchymal variants, which had the potential to further produce epithelial revertants autonomously. The successive acquisition of invasive mesenchymal and then epithelial phenotypes recapitulated the steps in tumor progression to metastasis. Importantly, the generation of mesenchymal variants from clonal epithelial populations was associated with subtle changes in chromosome content, which altered the chromosome transcriptome and influenced the expression of genes encoding intercellular junction (IJ) proteins, whereas the loss of chromosome 10p, which harbors the ZEB1 gene, was frequently detected in epithelial variants generated from mesenchymal clones. Knocking down these IJ genes in epithelial cells induced a mesenchymal phenotype, whereas knocking down the ZEB1 gene in mesenchymal cells induced an epithelial phenotype, demonstrating a causal role of chromosome content changes in phenotypic determination. Thus, our studies suggest a paradigm of tumor metastasis: primary epithelial carcinoma cells that lose chromosomes harboring IJ genes acquire an invasive mesenchymal phenotype, and subsequent chromosome content changes such as loss of 10p in disseminated mesenchymal cells generate epithelial variants, which can be selected for to generate epithelial tumors during metastatic colonization.

Entities:  

Keywords:  aneuploidy; chromosome instability; clonal evolution; epithelial–mesenchymal transition (E-MT); tumor metastasis

Mesh:

Substances:

Year:  2016        PMID: 27930335      PMCID: PMC5187712          DOI: 10.1073/pnas.1618215113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

Review 1.  To differentiate or not--routes towards metastasis.

Authors:  Thomas Brabletz
Journal:  Nat Rev Cancer       Date:  2012-05-11       Impact factor: 60.716

Review 2.  The consequences of chromosomal aneuploidy on the transcriptome of cancer cells.

Authors:  Thomas Ried; Yue Hu; Michael J Difilippantonio; B Michael Ghadimi; Marian Grade; Jordi Camps
Journal:  Biochim Biophys Acta       Date:  2012-03-06

3.  The patterns and dynamics of genomic instability in metastatic pancreatic cancer.

Authors:  Peter J Campbell; Shinichi Yachida; Laura J Mudie; Philip J Stephens; Erin D Pleasance; Lucy A Stebbings; Laura A Morsberger; Calli Latimer; Stuart McLaren; Meng-Lay Lin; David J McBride; Ignacio Varela; Serena A Nik-Zainal; Catherine Leroy; Mingming Jia; Andrew Menzies; Adam P Butler; Jon W Teague; Constance A Griffin; John Burton; Harold Swerdlow; Michael A Quail; Michael R Stratton; Christine Iacobuzio-Donahue; P Andrew Futreal
Journal:  Nature       Date:  2010-10-28       Impact factor: 49.962

4.  DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells.

Authors:  Andreas Eger; Kirsten Aigner; Stefan Sonderegger; Brigitta Dampier; Susanne Oehler; Martin Schreiber; Geert Berx; Amparo Cano; Hartmut Beug; Roland Foisner
Journal:  Oncogene       Date:  2005-03-31       Impact factor: 9.867

Review 5.  Clonal evolution in cancer.

Authors:  Mel Greaves; Carlo C Maley
Journal:  Nature       Date:  2012-01-18       Impact factor: 49.962

6.  Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded.

Authors:  Jianzhong Yu; Yonggang Zheng; Jixin Dong; Stephen Klusza; Wu-Min Deng; Duojia Pan
Journal:  Dev Cell       Date:  2010-02-16       Impact factor: 12.270

Review 7.  Metastasis as an evolutionary process.

Authors:  Samra Turajlic; Charles Swanton
Journal:  Science       Date:  2016-04-08       Impact factor: 47.728

8.  Heterogeneity in cancer: cancer stem cells versus clonal evolution.

Authors:  Mark Shackleton; Elsa Quintana; Eric R Fearon; Sean J Morrison
Journal:  Cell       Date:  2009-09-04       Impact factor: 41.582

9.  Chromosome instability, chromosome transcriptome, and clonal evolution of tumor cell populations.

Authors:  ChongFeng Gao; Kyle Furge; Julie Koeman; Karl Dykema; Yanli Su; Mary Lou Cutler; Adam Werts; Pete Haak; George F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-15       Impact factor: 11.205

10.  Cancer karyotypes: survival of the fittest.

Authors:  Joshua M Nicholson; Daniela Cimini
Journal:  Front Oncol       Date:  2013-06-07       Impact factor: 6.244

View more
  23 in total

Review 1.  Mutation-selection balance and compensatory mechanisms in tumour evolution.

Authors:  Erez Persi; Yuri I Wolf; David Horn; Eytan Ruppin; Francesca Demichelis; Robert A Gatenby; Robert J Gillies; Eugene V Koonin
Journal:  Nat Rev Genet       Date:  2020-11-30       Impact factor: 53.242

2.  Extensive protein dosage compensation in aneuploid human cancers.

Authors:  Klaske M Schukken; Jason M Sheltzer
Journal:  Genome Res       Date:  2022-06-14       Impact factor: 9.438

Review 3.  MYC and RAF: Key Effectors in Cellular Signaling and Major Drivers in Human Cancer.

Authors:  Eduard Stefan; Klaus Bister
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

Review 4.  Aneuploidy as a promoter and suppressor of malignant growth.

Authors:  Anand Vasudevan; Klaske M Schukken; Erin L Sausville; Vishruth Girish; Oluwadamilare A Adebambo; Jason M Sheltzer
Journal:  Nat Rev Cancer       Date:  2021-01-11       Impact factor: 69.800

5.  The 150 most important questions in cancer research and clinical oncology series: questions 67-75 : Edited by Chinese Journal of Cancer.

Authors: 
Journal:  Chin J Cancer       Date:  2017-11-01

6.  Single-Gene Deletions Contributing to Loss of Heterozygosity in Saccharomyces cerevisiae: Genome-Wide Screens and Reproducibility.

Authors:  Kellyn M Hoffert; Erin D Strome
Journal:  G3 (Bethesda)       Date:  2019-09-04       Impact factor: 3.154

Review 7.  Evolving Therapeutic Strategies to Exploit Chromosome Instability in Cancer.

Authors:  Laura L Thompson; Lucile M-P Jeusset; Chloe C Lepage; Kirk J McManus
Journal:  Cancers (Basel)       Date:  2017-11-01       Impact factor: 6.639

8.  Is cancer progression caused by gradual or simultaneous acquisitions of new chromosomes?

Authors:  Mathew Bloomfield; Peter Duesberg
Journal:  Mol Cytogenet       Date:  2018-01-15       Impact factor: 2.009

Review 9.  Understanding aneuploidy in cancer through the lens of system inheritance, fuzzy inheritance and emergence of new genome systems.

Authors:  Christine J Ye; Sarah Regan; Guo Liu; Sarah Alemara; Henry H Heng
Journal:  Mol Cytogenet       Date:  2018-05-10       Impact factor: 2.009

10.  Twist1 induces chromosomal instability (CIN) in colorectal cancer cells.

Authors:  Maithilee Khot; Dyuthi Sreekumar; Sanika Jahagirdar; Apoorva Kulkarni; Kishore Hari; Elangoli Ebrahimkutty Faseela; Radhakrishnan Sabarinathan; Mohit Kumar Jolly; Kundan Sengupta
Journal:  Hum Mol Genet       Date:  2020-06-27       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.